Concepedia

Frederik Teicher Kirk

FT

Statistics

Publications

5

Citations

146

H-Index

5

Active since

2022

Affiliations

Aarhus University Hospital(Current)

Aarhus University

AstraZeneca (United States)

Alexion Pharmaceuticals (United States)

Yale University

Frederik Teicher Kirk is an author at Aarhus University Hospital specializing in copper metabolism, intestinal copper metabolism, and pharmacology.

ORCID

Publications per year

2022–2025

5

Publications

5

Effects of tetrathiomolybdate on copper metabolism in healthy volunteers and in patients with Wilson disease

Frederik Teicher Kirk, Ditte Emilie Munk, Eugene Swenson et al. · Journal of Hepatology · 2023 · 72 citations · Full text

, , +16

Effects of trientine and penicillamine on intestinal copper uptake: A mechanistic 64Cu PET/CT study in healthy humans

Frederik Teicher Kirk, Ditte Emilie Munk, Eugene Swenson et al. · Hepatology · 2023 · 28 citations · Full text

, , +15

Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study

Ditte Emilie Munk, Tea Lund Laursen, Frederik Teicher Kirk et al. · Scientific Reports · 2022 · 23 citations · Full text

, , +17

Distribution of non-ceruloplasmin-bound copper after i.v. 64Cu injection studied with PET/CT in patients with Wilson disease

Ditte Emilie Munk, Mikkel Holm Vendelbo, Frederik Teicher Kirk et al. · JHEP Reports · 2023 · 12 citations · Full text

, , +14

Relative Exchangeable Copper, Exchangeable Copper and Total Copper in the Diagnosis of Wilson Disease

C. L. Lorenzen, Karen Dons, Clàudia García‐Solà et al. · Liver International · 2025 · 11 citations · Full text

, , +14

1–5 of 5